- Report
- May 2025
- 231 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- May 2025
- 218 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- May 2025
- 216 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- May 2025
- 225 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- May 2025
- 223 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- April 2025
- 251 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- April 2025
- 233 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- April 2025
- 217 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 210 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 205 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 228 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 226 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 222 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 217 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- March 2025
- 194 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 247 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 252 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 231 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 233 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 215 Pages
Global
From €2210EUR$2,500USD£1,908GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more